drug-abuse

Documents about drug-abuse

• A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users#901669ClinicalTrials.gov
• Ph1 Lobeline Interaction Study - 1#828906ClinicalTrials.gov
• Selegiline for Smoking Cessation - 1#879327ClinicalTrials.gov
• Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment#842140ClinicalTrials.gov
• Reducing the Abuse of Opioids in Drug Users#890602ClinicalTrials.gov
• Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users#903236ClinicalTrials.gov
• Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers#813747ClinicalTrials.gov
• Intervention to Reduce Injection Drug Use#893999ClinicalTrials.gov
• The Road to Mandalay: A Tale of Burma#39411Project Gutenberg
• Ondansetron for the Treatment of Cocaine Dependence - 1#1047686ClinicalTrials.gov
• Rivastigmine For Methamphetamine Dependent Individuals#829506ClinicalTrials.gov
• Increasing Caregiver Engagement in Juvenile Drug Courts#843149ClinicalTrials.gov
• Interactive Motivational Media for Perinatal Drug Abuse - 3#908362ClinicalTrials.gov
• Buprenorphine Naltrexone-P1 A-Cocaine#992054ClinicalTrials.gov
• 20 U.S.C. § 1011i — Drug and alcohol abuse prevention#576424US Code (LII)
• 21 U.S.C. § 1171 — Drug abuse prevention function appropriations#576948US Code (LII)
• 21 U.S.C. § 1179 — National Drug Abuse Training Center#576955US Code (LII)
• Social ecological factors affecting substance abuse in Ghana (West Africa) using photovoice#20062DOAJ
• EEG Monitoring in the Emergency Department#914814ClinicalTrials.gov
• Non-Treatment Study of Factors Affecting Cocaine Drug Choice#865579ClinicalTrials.gov
• High Dose Nimodipine Treatment Adjunct - 1#860272ClinicalTrials.gov
• Environment and Alcohol: A Pilot Study#898756ClinicalTrials.gov
• Comparison of Buprenorphine and Methadone - 3#969315ClinicalTrials.gov
• Relapse Patterns in Female Cocaine Users - 4#982137ClinicalTrials.gov
• Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication#909934ClinicalTrials.gov
• An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users#253050ClinicalTrials.gov
• Evaluation of Oral THC and CBD in Men and Women#871755ClinicalTrials.gov
• Individual Differences in Reward and Impulse Control#887284ClinicalTrials.gov
• Substance Dependent Teens - Impact of Treating Depression Study 1 - 1#800522ClinicalTrials.gov
• Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment#867529ClinicalTrials.gov
• Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico#982304ClinicalTrials.gov
• Development of a Community-based Network for Drug Abusers#1007997ClinicalTrials.gov
• Alternate-Day Buprenorphine Administration. Phase II - 4#839120ClinicalTrials.gov
• Dextroamphetamine-Cocaine Behavioral Intervention - 5#842910ClinicalTrials.gov
• Double Blind Placebo Control Opipramol-Baclofen Treatment for Addiction#896593ClinicalTrials.gov
• 29 U.S.C. § 566 — Employee drug and alcohol abuse assistance programs#584041US Code (LII)
• 42 U.S.C. § 11922 — Clearinghouse on drug abuse in public housing#589953US Code (LII)
• Development and validation of the screening tool for identifying elder abuse by caregivers (STIEAC)#289128PLOS
• ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and Poisoning#868603ClinicalTrials.gov
• Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics#889219ClinicalTrials.gov
• Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals#842214ClinicalTrials.gov
• Cannabis Effects as a Function of Sex#825137ClinicalTrials.gov
• Propranolol for Treatment of Cocaine Addiction - 2#827305ClinicalTrials.gov
• Opioid Agonist and Antagonist Effects on Opioid Dependence#829836ClinicalTrials.gov
• Atomoxetine for the Treatment of Cannabis Dependence#843140ClinicalTrials.gov
• Infusion Laboratory: Protocol 5 (Flupenthixol) - 14#856283ClinicalTrials.gov
• Role of Metabolites in Nicotine Dependence (3) - 6#881351ClinicalTrials.gov
• Brief Strategic Family Therapy for Adolescent Drug Abusers#902319ClinicalTrials.gov
• Assessment of Interactions Between Methamphetamine and Aripiprazole - 1#915307ClinicalTrials.gov
• 42 U.S.C. § 11842 — Evaluation of drug abuse education and prevention efforts#589969US Code (LII)